The rapidly developing COVID-19 crisis is affecting global companies in their main production and sales markets.

Many internal crisis teams are currently reaching their capacity and load limits. It is becoming increasingly difficult to react appro­priately to the situation, to make decisions and to consistently monitor the implementation of these decisions and the associated action plans.

The ACTRANS team has significant experience in supporting com­pa­nies in crisis situations. Our team is interdisciplinary and consists of experienced managers, consultants and medical doctors.

ACTRANS Model for Crisis Support

Illustration "Business continuity management"

Specifically, we support the internal crisis teams in completing their tasks e.g. creation of dialy situational aware­ness, the eva­luation and implementation of measures as well as internal and external communication.

COVID-19 crisis checklist

ACTRANS has created a COVID-19 crisis checklist, which helps you to identify the maturity of your measures. Please find for download here:

For further information about the COVID-19 crisis management of ACTRANS please download our presentation:

For short-term support in crisis management, please contact us on +49 89 215 41916 or by email Dr. Mike Körner, Partner (Mike.Koerner@actrans.de) or Dr. Martin Kraus, Partner (Martin.Kraus@actrans.de)

The Munich based management consultancy ACTRANS has established an advisory board to support our management actively in the successful development of ACTRANS GmbH. With Bernhard Gerwert and Bodo Garbe, two outstanding personalities with many years of experience and responsibility in the defence industry joined the advisory board.

Bernhard Gerwert has more than 35 years of experience in the defence and aerospace industry. From 2013 to mid-2016, he served as CEO of Airbus Defence and Space.

Bodo Garbe has more than 30 years of experience in the defence industry. He was a member of the Board of Management of Rheinmetall Defence as well as Head of the Division Electronic Solutions.

For more information see: Senior Advisory Committee